Biotechnology

#Biotechnology #Cancer research #Clinical trials #Drug development #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (19-23 October)

News round-up for 19-23 October 2026 by Megan Thomas, Multimedia Editor at DDW.  In this week’s news roundup, drug discovery and biopharma companies continue to make progress across the drug development pipeline, with recent updates highlighting clinical trial milestones, emerging research and investment in new treatments. The… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Rare disease #Technology #Tumours

This week in Drug Discovery (12-16 October)

News round-up for 12-16 October 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as new initiatives to accelerate rare disease drug development, promising preclinical data for Duchenne muscular dystrophy, clinical trial… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (5-9 October 2026) 

News round-up for 5-9 October, 2026 by Megan Thomas, Multimedia Editor at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as some promising updates in cancer research and immunotherapy, particularly the development of new treatments and how… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (28 September – 2 October 2026) 

News round-up for 28 September – 2 October 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming the Drug Discovery Innovators & Investors Conference in London, as well as global updates on cancer research. The top stories:  In-person… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (21-25 September 2026) 

News round-up for 21-25 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, as well as the latest developments in drug discovery,… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (14-18 September 2026) 

News round-up for 14-18 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, changes to US scientific research grant screening, the UK’s… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (7-11 September 2026) 

News round-up for 7-11 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers upcoming Drug Discovery Innovators & Investors (DDII) in-person events and forum updates, alongside the latest Phase II clinical data across coeliac disease, bronchiectasis and head and neck cancer. Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (31 August – 4 September 2026) 

News round-up for 31 August – 4 September 2026 by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new developments in vaccines, drug approvals, cardiovascular therapies and cancer drug response, alongside DDW’s upcoming digital forum focused on the technologies, strategies and investment trends shaping… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (17-21 August 2026) 

News round-up for 17-21 August by Megan Thomas, Content Team at DDW.  This week’s news roundup covers new therapeutic approaches moving towards or through clinical development, alongside advances in drug discovery and the investment landscape supporting biotech innovation. The top stories:  DDII Digital Forum:… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (10-14 August 2026) 

News round-up for 10-14 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new discoveries in cancer research, including the first trial of a new type of immunotherapy, an immune cell finding that could transform cancer treatment, and a groundbreaking drug… Read More

#News

Gene editing concept
#Biotechnology #Broken String Biosciences #Gene editing #Genetic medicines #Genetics

Base editing to enable single-base genomic changes

Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, has launched BaseMap ABE. Built on the company’s INDUCE-seq technology, BaseMap ABE extends the platform’s capabilities to support adenine base editing (ABE) applications. Base editing is rapidly gaining momentum as a… Read More

#News

#Biotechnology #Cancer research #Clinical trials #Drug discovery #Investment

This week in Drug Discovery (3-7 August 2026) 

News round-up for 3-7 August by Diana Turner, Content Team at DDW.  This week’s news round-up highlights new clinical trial results that demonstrate positive outcomes in Parkinson’s, colorectal cancer and Bundibugyo ebolavirus, as well as the first ever trial of a fridge-free vaccine. Elsewhere,… Read More

#News

#Biotechnology #Cancer research #DDII #DDIIDigitalForum #Drug discovery #Investment #Technology #Tumours

This week in Drug Discovery (27-31 July 2026) 

News round-up for 27-31 July by Megan Thomas, Content Team at DDW.  This week’s news roundup centres around investment, innovation and strategic growth, which have dominated this week’s headlines. Across the drug discovery sector, companies have secured funding, expanded R&D capabilities and accelerated the adoption of AI-driven… Read More

#News

#Biotechnology #Cancer research #Drug discovery #Tumours

This week in Drug Discovery (20-24 July 2026) 

News round-up for 20-24 July by Megan Thomas, Content Team at DDW.  This week’s news roundup highlights the latest advances in cancer research and treatment, from promising clinical trial updates to discoveries that could improve the body’s immune response to tumours. The top stories include progress in… Read More

#News

Human kidneys
#Biotechnology #Clinical stage biotechnology #Drug discovery #Funding #Rege Nephro #Regenerative Medicine

Rege Nephro secures US$10.6m for ADPKD and beyond

Rege Nephro, a Japanese clinical-stage biotechnology company focused on iPS cell-based kidney regenerative medicine and drug discovery, has closed a financing round totalling approximately US$10.6 million. Through the issuance of Japan-Keep It Simple Security (J-KISS) share acquisition rights, proceeds are expected to support commercialisation activities for RN-014, the company’s lead… Read More

#News

Great British Pounds, Investment
#BioIndustry Association #Biotechnology #Investment #UK

UK biotech venture investment reaches a five-year high

UK biotech financing hit a five-year high in the second quarter of 2026, with total equity financing reaching £2.11 ($2.84) billion, including a record £2.05 ($2.76) billion in venture capital, according to new figures from the BioIndustry Association (BIA).  The quarter was dominated by Isomorphic Labs’ landmark… Read More

#Business & Investment #News